Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients

Recombinant adeno-associated viral vectors (rAAV) currently constitute a real therapeutic strategy for the sustained correction of diverse genetic conditions. Though a wealth of preclinical and clinical studies have been conducted with rAAV, the oncogenic potential of these vectors is still controve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gil-Fariña, Irene (VerfasserIn) , Fronza, Raffaele (VerfasserIn) , Schmidt, Manfred (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 5 April 2016
In: Molecular therapy
Year: 2016, Jahrgang: 24, Heft: 6, Pages: 1100-1105
ISSN:1525-0024
DOI:10.1038/mt.2016.52
Online-Zugang:Verlag, Volltext: https://doi.org/10.1038/mt.2016.52
Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923321/
Volltext
Verfasserangaben:Irene Gil-Farina, Raffaele Fronza, Christine Kaeppel, Esperanza Lopez-Franco, Valerie Ferreira, Delia D'Avola, Alberto Benito, Jesus Prieto, Harald Petry, Gloria Gonzalez-Aseguinolaza and Manfred Schmidt

MARC

LEADER 00000caa a2200000 c 4500
001 166257097X
003 DE-627
005 20230426172425.0
007 cr uuu---uuuuu
008 190329s2016 xx |||||o 00| ||eng c
024 7 |a 10.1038/mt.2016.52  |2 doi 
035 |a (DE-627)166257097X 
035 |a (DE-599)KXP166257097X 
035 |a (OCoLC)1341205891 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gil-Fariña, Irene  |e VerfasserIn  |0 (DE-588)114095301X  |0 (DE-627)898790999  |0 (DE-576)494156201  |4 aut 
245 1 0 |a Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients  |c Irene Gil-Farina, Raffaele Fronza, Christine Kaeppel, Esperanza Lopez-Franco, Valerie Ferreira, Delia D'Avola, Alberto Benito, Jesus Prieto, Harald Petry, Gloria Gonzalez-Aseguinolaza and Manfred Schmidt 
264 1 |c 5 April 2016 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.03.2019 
520 |a Recombinant adeno-associated viral vectors (rAAV) currently constitute a real therapeutic strategy for the sustained correction of diverse genetic conditions. Though a wealth of preclinical and clinical studies have been conducted with rAAV, the oncogenic potential of these vectors is still controversial, particularly when considering liver-directed gene therapy. Few preclinical studies and the recent discovery of incomplete wild-type AAV2 genomes integrated in human hepatocellular carcinoma biopsies have raised concerns on rAAV safety. In the present study, we have characterized the integration of both complete and partial rAAV2/5 genomes in nonhuman primate tissues and clinical liver biopsies from a trial aimed to treat acute intermittent porphyria. We applied a new multiplex linear amplification-mediated polymerase chain reaction (PCR) assay capable of detecting integration events that are originated throughout the rAAV genome. The integration rate was low both in nonhuman primates and patient's samples. Importantly, no integration clusters or events were found in genes previously reported to link rAAV integration with hepatocellular carcinoma development, thus showing the absence of genotoxicity of a systemically administered rAAV2/5 in a large animal model and in the clinical context. 
700 1 |a Fronza, Raffaele  |e VerfasserIn  |0 (DE-588)1048496406  |0 (DE-627)780549414  |0 (DE-576)40232935X  |4 aut 
700 1 |a Schmidt, Manfred  |d 1967-2022  |e VerfasserIn  |0 (DE-588)122922301  |0 (DE-627)706092430  |0 (DE-576)293477620  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy  |d Amsterdam : Elsevier, 2000  |g 24(2016), 6, Seite 1100-1105  |h Online-Ressource  |w (DE-627)320415198  |w (DE-600)2001818-6  |w (DE-576)104344695  |x 1525-0024  |7 nnas  |a Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients 
773 1 8 |g volume:24  |g year:2016  |g number:6  |g pages:1100-1105  |g extent:6  |a Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients 
856 4 0 |u https://doi.org/10.1038/mt.2016.52  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923321/  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190329 
993 |a Article 
994 |a 2016 
998 |g 122922301  |a Schmidt, Manfred  |m 122922301:Schmidt, Manfred  |d 140000  |e 140000PS122922301  |k 0/140000/  |p 11  |y j 
998 |g 1048496406  |a Fronza, Raffaele  |m 1048496406:Fronza, Raffaele  |d 910000  |e 910000PF1048496406  |k 0/910000/  |p 2 
998 |g 114095301X  |a Gil-Fariña, Irene  |m 114095301X:Gil-Fariña, Irene  |d 910000  |e 910000PG114095301X  |k 0/910000/  |p 1  |x j 
999 |a KXP-PPN166257097X  |e 3417506123 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients","title":"Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients"}],"person":[{"family":"Gil-Fariña","given":"Irene","roleDisplay":"VerfasserIn","display":"Gil-Fariña, Irene","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Fronza, Raffaele","given":"Raffaele","family":"Fronza"},{"roleDisplay":"VerfasserIn","display":"Schmidt, Manfred","role":"aut","family":"Schmidt","given":"Manfred"}],"language":["eng"],"recId":"166257097X","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 29.03.2019"],"id":{"doi":["10.1038/mt.2016.52"],"eki":["166257097X"]},"origin":[{"dateIssuedDisp":"5 April 2016","dateIssuedKey":"2016"}],"name":{"displayForm":["Irene Gil-Farina, Raffaele Fronza, Christine Kaeppel, Esperanza Lopez-Franco, Valerie Ferreira, Delia D'Avola, Alberto Benito, Jesus Prieto, Harald Petry, Gloria Gonzalez-Aseguinolaza and Manfred Schmidt"]},"relHost":[{"title":[{"title_sort":"Molecular therapy","title":"Molecular therapy","subtitle":"official journal of the American Society of Gene Therapy"}],"disp":"Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patientsMolecular therapy","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 28.05.2020"],"language":["eng"],"corporate":[{"display":"American Society of Gene Therapy","roleDisplay":"Herausgebendes Organ","role":"isb"}],"recId":"320415198","pubHistory":["1.2000 -"],"part":{"volume":"24","text":"24(2016), 6, Seite 1100-1105","extent":"6","year":"2016","pages":"1100-1105","issue":"6"},"origin":[{"publisher":"Elsevier ; Nature Publ. Group ; Acad. Press","dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla."}],"id":{"issn":["1525-0024"],"eki":["320415198"],"zdb":["2001818-6"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"6 S."}]} 
SRT |a GILFARINAIRECOMBINAN5201